Arcutis Biotherapeutics, Inc. (ARQT)
24.53
+0.34
(+1.41%)
USD |
NASDAQ |
Apr 17, 16:00
24.40
-0.13
(-0.53%)
Pre-Market: 20:00
Arcutis Biotherapeutics Free Cash Flow : -16.31M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Repligen Corp. | 91.69M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Corcept Therapeutics, Inc. | 141.78M |
| Amicus Therapeutics, Inc. | 29.85M |
| ADMA Biologics, Inc. | 27.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 26.18M |
| Cash from Investing (Quarterly) | -34.18M |
| Cash from Financing (Quarterly) | 3.722M |
| Free Cash Flow Per Share (Quarterly) | 0.1931 |
| Free Cash Flow to Equity (Quarterly) | 25.73M |
| Free Cash Flow to Firm (Quarterly) | 29.11M |
| Free Cash Flow Yield | -0.51% |